Ico Therapeutics Inc., of Vancouver, British Columbia, said it upsized its nonbrokered private placement to CA$1.25 million (US$942,695). Each unit issued consists of one common share and one common share purchase warrant exercisable at $0.075 for 36 months from the date of the closing. The private placement is expected to occur in several closings.